These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34904667)

  • 1. Plasma VP8∗-Binding Antibodies in Rotavirus Infection and Oral Vaccination in Young Bangladeshi Children.
    Lee B; Colgate ER; Carmolli M; Dickson DM; Gullickson S; Diehl SA; Ara R; Alam M; Kibria G; Abdul Kader M; Afreen S; Ferdous T; Haque R; Kirkpatrick BD
    J Pediatric Infect Dis Soc; 2022 Apr; 11(4):127-133. PubMed ID: 34904667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotavirus-Specific Immunoglobulin A Responses Are Impaired and Serve as a Suboptimal Correlate of Protection Among Infants in Bangladesh.
    Lee B; Carmolli M; Dickson DM; Colgate ER; Diehl SA; Uddin MI; Islam S; Hossain M; Rafique TA; Bhuiyan TR; Alam M; Nayak U; Mychaleckyj JC; McNeal MM; Petri WA; Qadri F; Haque R; Kirkpatrick BD
    Clin Infect Dis; 2018 Jul; 67(2):186-192. PubMed ID: 29394355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Immunogenicity of a Monovalent Parenteral P2-VP8 Subunit Rotavirus Vaccine and Fecal Shedding of Rotavirus following Rotarix Challenge during a Randomized, Double-Blind, Placebo-Controlled Trial.
    Fellows T; Page N; Fix A; Flores J; Cryz S; McNeal M; Iturriza-Gomara M; Groome MJ
    Viruses; 2023 Aug; 15(9):. PubMed ID: 37766217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Rotavirus-specific IgA and Risk of Rotavirus Vaccine Failure in Infants in Malawi.
    Pollock L; Bennett A; Jere KC; Mandolo J; Dube Q; Bar-Zeev N; Heyderman RS; Cunliffe NA; Iturriza-Gomara M
    Clin Infect Dis; 2022 Aug; 75(1):41-46. PubMed ID: 34788820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus vaccination and infection induce VP6-specific IgA responses.
    Lappalainen S; Blazevic V; Malm M; Vesikari T
    J Med Virol; 2017 Feb; 89(2):239-245. PubMed ID: 27431308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactogenicity and safety of a liquid human rotavirus vaccine (RIX4414) in healthy adults, children and infants in China: randomized, double-blind, placebo-controlled Phase I studies.
    Li RC; Li YP; Mo ZJ; Luo D; Huang T; Kong JL; Wang LH; Song NS; Liu A; Zhang H; Liao X; Karkada N; Han HH
    Hum Vaccin Immunother; 2013 Aug; 9(8):1638-42. PubMed ID: 23807360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of a parenterally administered rotavirus VP8 subunit vaccine in healthy adults.
    Fix AD; Harro C; McNeal M; Dally L; Flores J; Robertson G; Boslego JW; Cryz S
    Vaccine; 2015 Jul; 33(31):3766-72. PubMed ID: 26065919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of immune protection against human rotaviruses: natural infection and vaccination.
    Latifi T; Kachooei A; Jalilvand S; Zafarian S; Roohvand F; Shoja Z
    Arch Virol; 2024 Mar; 169(3):72. PubMed ID: 38459213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: analysis of clinical trials of human rotavirus vaccine.
    Cheuvart B; Neuzil KM; Steele AD; Cunliffe N; Madhi SA; Karkada N; Han HH; Vinals C
    Hum Vaccin Immunother; 2014; 10(2):505-11. PubMed ID: 24240068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants.
    Chilengi R; Simuyandi M; Beach L; Mwila K; Becker-Dreps S; Emperador DM; Velasquez DE; Bosomprah S; Jiang B
    PLoS One; 2016; 11(3):e0150100. PubMed ID: 26974432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial.
    Groome MJ; Koen A; Fix A; Page N; Jose L; Madhi SA; McNeal M; Dally L; Cho I; Power M; Flores J; Cryz S
    Lancet Infect Dis; 2017 Aug; 17(8):843-853. PubMed ID: 28483414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis.
    Middleton BF; Jones MA; Waddington CS; Danchin M; McCallum C; Gallagher S; Leach AJ; Andrews R; Kirkwood C; Cunliffe N; Carapetis J; Marsh JA; Snelling T
    BMJ Open; 2019 Nov; 9(11):e032549. PubMed ID: 31727664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of all-cause and rotavirus acute gastroenteritis and the characteristics of rotavirus circulating strains before and after rotavirus vaccine introduction in Yemen: analysis of hospital-based surveillance data.
    Banajeh SM; Abu-Asba BA
    BMC Infect Dis; 2015 Oct; 15():418. PubMed ID: 26464210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of G2P[4] strain evolution and rotavirus vaccination: A review of evidence for Rotarix.
    Bibera GL; Chen J; Pereira P; Benninghoff B
    Vaccine; 2020 Jul; 38(35):5591-5600. PubMed ID: 32651115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotavirus genotypes and clinical outcome of natural infection based on vaccination status in the post-vaccine era.
    Kozawa K; Higashimoto Y; Kawamura Y; Miura H; Negishi T; Hattori F; Ihira M; Komoto S; Taniguchi K; Yoshikawa T
    Hum Vaccin Immunother; 2022 Dec; 18(1):2037983. PubMed ID: 35240934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of circulating intestinally committed memory B cells in children vaccinated with attenuated human rotavirus vaccine.
    Rojas OL; Caicedo L; Guzmán C; Rodríguez LS; Castañeda J; Uribe L; Andrade Y; Pinzón R; Narváez CF; Lozano JM; De Vos B; Franco MA; Angel J
    Viral Immunol; 2007; 20(2):300-11. PubMed ID: 17603846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of rhesus rotavirus vaccine MMU-18006 against gastroenteritis due to serotype 1 rotavirus.
    Ukae S; Nakata S; Adachi N; Kogawa K; Chiba S
    Vaccine; 1994 Aug; 12(10):933-9. PubMed ID: 7975835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postvaccination Serum Antirotavirus Immunoglobulin A as a Correlate of Protection Against Rotavirus Gastroenteritis Across Settings.
    Baker JM; Tate JE; Leon J; Haber MJ; Pitzer VE; Lopman BA
    J Infect Dis; 2020 Jun; 222(2):309-318. PubMed ID: 32060525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants.
    Moon SS; Groome MJ; Velasquez DE; Parashar UD; Jones S; Koen A; van Niekerk N; Jiang B; Madhi SA
    Clin Infect Dis; 2016 Jan; 62(2):157-65. PubMed ID: 26400993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, Immunogenicity and Safety of a Human Rotavirus Vaccine RIX4414 in Singaporean Infants.
    Phua KB; Lim FS; Quak SH; Lee BW; Teoh YL; Suryakiran PV; Han HH; Bock HL
    Ann Acad Med Singap; 2016 Feb; 45(2):44-50. PubMed ID: 27125345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.